|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Net loss from continuing operations | |||||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities | |||||
| Depreciation and amortization | |||||
| Amortization of deferred financing fees and issuance discount | |||||
| Deferred income tax (benefit) | |||||
| Share-based compensation expense | |||||
| Earnings of unconsolidated affiliate, net of dividends | |||||
| Unrealized net (gain) loss on foreign exchange forward contracts | |||||
| Unrealized net (gain) loss on commodity economic swap contracts | |||||
| Pension curtailment and settlement (gain) loss | |||||
| Loss on extinguishment of long-term debt | |||||
| Gain on sale of other assets | |||||
| Impairment charges or write-offs | |||||
| Changes in assets and liabilities | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Accounts payable and other current liabilities | |||||
| Income taxes payable | |||||
| Other assets, net | |||||
| Other liabilities, net | |||||
| Cash used in operating activities - continuing operations | |||||
| Cash provided by (used in) operating activities | |||||
| Cash flows from investing activities | |||||
| Capital expenditures | |||||
| Proceeds from the sale of other assets | |||||
| Cash used in investing activities - continuing operations | |||||
| Cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Deferred financing fees | |||||
| Short-term borrowings, net | |||||
| Dividends paid | |||||
| Proceeds from exercise of option awards | |||||
| Withholding taxes paid on restricted share units | |||||
| Acquisition-related contingent consideration payment | |||||
| Repurchases and repayments of long-term debt | |||||
| Net proceeds from issuance of 2028 Refinance Term Loans | |||||
| 2028 Refinance Term Loans | |||||
| Total net proceeds from issuance of 2028 Refinance Term Loans | |||||
| Proceeds from Accounts Receivable Securitization Facility | |||||
| Repayments of Accounts Receivable Securitization Facility | |||||
| Proceeds from Revolving Facility | |||||
| Repayments of Revolving Facility | |||||
| Cash provided by (used in) financing activities | |||||
| Effect of exchange rates on cash | |||||
| Net change in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash-beginning of period | |||||
| Cash, cash equivalents, and restricted cash-end of period | |||||
| Less: Restricted cash | |||||
| Cash and cash equivalents-end of period | |||||
| 2028 Refinance Term Loans | |||||
| Total cash and cash equivalents-end of period | |||||
| Supplemental disclosure of cash flow information | |||||
| Net cash paid | |||||
| Cash paid for income taxes, net of refunds | |||||
| Cash paid for interest, net of amounts capitalized | |||||
| Accrual for property, plant and equipment | |||||
Loading...